| 1 |
Mark Waldman |
Global Trademarks |
6 |
| 1 |
John B. Stetson, Jr. |
Lockheed Martin |
6 |
| 3 |
Dene H. Taylor |
Temptime |
4 |
| 3 |
Alicia Regueiro-Ren |
Bristol-Myers Squibb |
4 |
| 3 |
Nicholas J. Thompson |
Comcast |
4 |
| 3 |
Jonathan Singer |
Chiral Photonics |
4 |
| #7 |
Wayne E. Childers |
Amerimas Home Products |
3 |
| #7 |
David Weinstein |
The Meet Group |
3 |
| #7 |
Mohsen N. Harandi |
ExxonMobil |
3 |
| #10 |
John D. LIPANI |
— |
2 |
| #10 |
Audris Huang |
Bristol-Myers Squibb |
2 |
| #10 |
Robert H. Spencer |
Cara Therapeutics |
2 |
| #10 |
Michael J. Orwat |
Bristol-Myers Squibb |
2 |
| #10 |
Jeff Castelli |
Amicus Therapeutics |
2 |
| #10 |
Fred Pether |
Oneworld Design & Manufacturing Group |
2 |
| #10 |
Andrew J. Tebben |
Bristol-Myers Squibb |
2 |
| #10 |
Heather Ansorge |
Lifecell |
2 |
| #18 |
Jeffrey A. Robl |
Bristol-Myers Squibb |
1 |
| #18 |
Bruce R. Rowley |
Bayer Intellectual Property Gmbh |
1 |
| #18 |
Stuart Carlitz |
— |
1 |
| #18 |
Hong Wu |
Bristol-Myers Squibb |
1 |
| #18 |
James V. Russell |
R & D Circuits |
1 |
| #18 |
John DeAndrea |
Finisar |
1 |
| #18 |
Kim E. ZERBA |
Celera |
1 |
| #18 |
Keith Kiser |
AT&T |
1 |
| #18 |
Mark Colyar |
Finisar |
1 |
| #18 |
Daniel O'Malley |
Innate Tumor Immunity |
1 |
| #18 |
Hung V. Do |
Amicus Therapeutics |
1 |
| #18 |
Michael E. Mertzman |
Bristol-Myers Squibb |
1 |
| #18 |
Ricardo De Oliveira |
Edgewell Personal Care Brands |
1 |
| #18 |
Michael S. Lontchar |
— |
1 |
| #18 |
Cailan Wang |
Bristol-Myers Squibb |
1 |
| #18 |
Daniel Joseph Niedziocha |
Scientific Instrument Services |
1 |
| #18 |
H. Robert Tiffany |
Tiffany & Tiffany Designers |
1 |
| #18 |
Kim Thomas Lancaster |
Lockheed Martin |
1 |
| #18 |
David E. Wachob |
Antronix |
1 |
| #18 |
John Halko, IV |
Unknown |
1 |
| #18 |
Eric E. Thompson |
Emhart |
1 |